Recent research is focusing on identifying new targets within the DNA repair pathways to increase the sensitivity of cancer cells to cross-linking agents. Additionally, precision medicine approaches are being developed to tailor treatments based on a patient's specific genetic makeup and the repair capabilities of their cancer cells. Innovations in this area aim to minimize side effects and improve the overall effectiveness of cancer treatments.
